Cargando…

Effect of rituximab dose on induction therapy in ABO-incompatible living kidney transplantation: A network meta-analysis

BACKGROUND: Rituximab is an induction immunosuppressant essential for ABO-incompatible kidney transplantation (ABOi KT). However, studies on its dosing, which differs among countries and transplant centers, are lacking. Therefore, we retrospectively investigated the effectiveness of the induction do...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Hee Ryong, Kim, Kipyo, Lee, Seoung Woo, Song, Joon Ho, Lee, Jin Ho, Hwang, Seun Deuk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	5200
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969271/ https://www.ncbi.nlm.nih.gov/pubmed/33725841 http://dx.doi.org/10.1097/MD.0000000000024853

Ejemplares similares

ABO-incompatible liver transplantation using only rituximab for patients with low anti-ABO antibody titer
por: Lee, Boram, et al.
Publicado: (2019)

Rituximab alone as induction therapy for membranous lupus nephritis: A multicenter retrospective study
por: Chavarot, Nathalie, et al.
Publicado: (2017)

Factors associated with rituximab-mediated B cell depletion in ABO-incompatible adult living donor liver transplantation
por: Hong, Suk Kyun, et al.
Publicado: (2023)

Potassium Channel Syndrome Caused by Nicorandil in Chronic Kidney Disease: A Case Report and Literature Review
por: Kim, Ji-Eun, et al.
Publicado: (2022)

Role of Plasma Exchange in ABO-incompatible Kidney Transplantation
por: Yoo, Soohun, et al.
Publicado: (2012)

Early hospital readmissions after ABO- or HLA- incompatible living donor kidney transplantation
por: Lee, Juhan, et al.
Publicado: (2019)

Rituximab Induction to Prevent the Recurrence of PSC After Liver Transplantation—The Lessons Learned From ABO-Incompatible Living Donor Liver Transplantation
por: Yamada, Yohei, et al.
Publicado: (2018)

Impact of ABO incompatible kidney transplantation on living donor transplantation
por: Yu, Ji Hyun, et al.
Publicado: (2017)

Successful kidney transplantation after desensitization in a patient with positive flow crossmatching and donor-specific anti-HLA-DP antibody: A Case report
por: Song, Seung Hwan, et al.
Publicado: (2016)

Acoustic Radiation Force Impulse Measurement in Renal Transplantation: A Prospective, Longitudinal Study With Protocol Biopsies
por: Lee, Juhan, et al.
Publicado: (2015)

Adult Living Donor Liver Transplantation Across ABO-Incompatibility
por: Lee, Chen-Fang, et al.
Publicado: (2015)

Systematic evaluation of different doses of cyclophosphamide induction therapy for lupus nephritis
por: Tian, Ming, et al.
Publicado: (2017)

Perioperative ABO Blood Group Isoagglutinin Titer and the Risk of Acute Kidney Injury after ABO-Incompatible Living Donor Liver Transplantation
por: Cho, Hyeyeon, et al.
Publicado: (2021)

No diffuse intrahepatic biliary stricture after ABO-incompatible adult living donor liver transplantation using tailored rituximab-based desensitization protocol
por: Natsuda, Koji, et al.
Publicado: (2021)

Serum Sclerostin as an Independent Marker of Peripheral Arterial Stiffness in Renal Transplantation Recipients: A Cross-Sectional Study
por: Hsu, Bang-Gee, et al.
Publicado: (2016)

Short-term results of ABO-incompatible living donor kidney transplantation: comparison with ABO-compatible grafts
por: Hwang, Jeong Kye, et al.
Publicado: (2011)

Successful kidney transplantation across a positive complement-dependent cytotoxicity crossmatch by using C1q assay-directed, bortezomib-assisted desensitization: A case report
por: Lee, Juhan, et al.
Publicado: (2017)

ABO-Incompatible Adult Living Donor Liver Transplantation in the Era of Rituximab: A Systematic Review and Meta-Analysis
por: Yadav, Dipesh Kumar, et al.
Publicado: (2019)

Cyclophosphamide induction dose and outcomes in ANCA-associated vasculitis with renal involvement: A comparative cohort study
por: Speer, Claudius, et al.
Publicado: (2021)

ABO-Incompatible Kidney Transplantation
por: Morath, Christian, et al.
Publicado: (2017)

ABO incompatibility in renal transplantation
por: Mohamed, Mahmoud, et al.
Publicado: (2021)

Comparison of Liver Graft Regeneration Between ABO-Compatible and ABO-Incompatible Living Donor Liver Transplantation: A Propensity Score Matching Analysis
por: Chae, Min Suk, et al.
Publicado: (2018)

Efficacy and safety of rituximab in the treatment of membranous nephropathy: A systematic review and meta-analysis
por: Lu, WanJun, et al.
Publicado: (2020)

Rituximab in treatment of anti-GBM antibody glomerulonephritis: A case report and literature review
por: Uematsu-Uchida, Mayu, et al.
Publicado: (2019)

Influence of Transfusion on the Risk of Acute Kidney Injury: ABO-Compatible versus ABO-Incompatible Liver Transplantation
por: Yu, Je Hyuk, et al.
Publicado: (2019)

Rituximab for the Treatment of IgG4-Related Tubulointerstitial Nephritis: Case Report and Review of the Literature
por: McMahon, Blaithin A., et al.
Publicado: (2015)

Emergency, ABO-Incompatible Living Donor Liver Re-Transplantation for Graft Failure Complicated by Pneumonia-Associated Sepsis
por: Kim, Seoung Hoon, et al.
Publicado: (2023)

Pre-transplant Evaluation of Donor Urinary Biomarkers can Predict Reduced Graft Function After Deceased Donor Kidney Transplantation
por: Koo, Tai Yeon, et al.
Publicado: (2016)

Rituximab shows no effect on remission in patients with refractory nephrotic syndrome: A MOOSE-compliant meta-analysis
por: Yin, Supei, et al.
Publicado: (2016)

The Outcomes of Hypertransfusion in Major ABO Incompatible Allogeneic Stem Cell Transplantation
por: Park, Se Hoon, et al.
Publicado: (2004)

Long-Term Prognosis of Adult Patients with Steroid-Dependent Minimal Change Nephrotic Syndrome Following Rituximab Treatment
por: Iwabuchi, Yuko, et al.
Publicado: (2014)

ABO-incompatible living-donor pediatric kidney transplantation in Japan
por: Aikawa, Atsushi, et al.
Publicado: (2014)

Latest insights on ABO‐incompatible living‐donor renal transplantation
por: Uchida, Junji, et al.
Publicado: (2019)

Effects of Neutralization by Soluble ABH Antigens Produced by Transplanted Kidneys From ABO-Incompatible Secretor Donors
por: Kim, Jieun, et al.
Publicado: (2017)

Increased Risk of Post-Transplant Malignancy and Mortality in Transplant Tourists: A Nationwide Population-Based Cohort Study in Taiwan
por: Chung, Mu-Chi, et al.
Publicado: (2014)

ABO-Incompatible Liver Transplantation under the Desensitization Protocol with Rituximab: Effect on Biliary Microbiota and Metabolites
por: Xiao, Min, et al.
Publicado: (2022)

Clinical Relevance of Isoagglutinin Rebound in Adult ABO-Incompatible Living Donor Liver Transplantation
por: Lee, Wei-Chen, et al.
Publicado: (2021)

Expansion and characterization of regulatory T cell populations from Korean kidney transplant recipients
por: Paek, Jin Hyuk, et al.
Publicado: (2023)

Clinical Significance of HLA-DQ Antibodies in the Development of Chronic Antibody-Mediated Rejection and Allograft Failure in Kidney Transplant Recipients
por: Lee, Hyeyoung, et al.
Publicado: (2016)

Efficacy of rituximab and plasmapharesis in an adult patient with antifactor H autoantibody-associated hemolytic uremic syndrome: A case report and literature review
por: Deville, Clemence, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_n4jq3olsl6b242m1l8qqbmfake